RxDoctor Payments Data

Sherril Durbin, DO

Family Medicine · Arlington, TXNPI 1245235993

Payments from drug & device makers

$2,907in general payments, 2019–2025

Across 155 payments — averaging $18.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$574
  • Lilly USA, LLC$456
  • Pfizer$374
  • Novo Nordisk$228
  • Boehringer Ingelheim$188
  • GSK$175
  • plus $912 from 17 others

What the payments were for

  • Food & beverage$2,81797%
  • Education$903%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,907 in reported general payments places this provider in the 75th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$68,269
Medicare patients
125
Services billed
640

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin40$54,977
JanuviaSitagliptin Phosphate20$21,333
MounjaroTirzepatide20$21,296
EliquisApixaban25$16,820
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog15$7,792
SymbicortBudesonide/Formoterol Fumarate19$6,802
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr12$5,844
Humalog Mix 75-25 KwikpenInsulin Lispro Protamin/Lispro11$3,227
Lantus SolostarInsulin Glargine,hum.Rec.Anlog21$2,319
Albuterol Sulfate HfaAlbuterol Sulfate68$1,906
Atorvastatin Calcium194$1,753
Novolog FlexpenInsulin Aspart12$1,555
Gabapentin105$1,489
Pantoprazole Sodium77$1,058
Lisinopril130$903

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$188$54,97740 claims
Lilly USA, LLCMounjaro$456$21,29620 claims
PfizerEliquis$374$16,82025 claims
AstraZenecaSymbicort$67$6,80219 claims
GSKAnoro Ellipta$175$5,84412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Arlington

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →